Abstract:There are several scientific approaches for the determination of cellular growth influences of known or novel substances under in vitro conditions, among which colourimetric absorption measurement is considered to be one of the convenient methods. [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] (MTS) assay is one of the commonly used colourimetric absorption assays based on the ability of dehydrogenase from viable cells to produce the brown soluble formazan detectable at 490 nm. Here we have tested the possible growth influence of iron (II) sulphate on two human cancer cell lines, the K562 chronic myelogenous leukaemia and T47D breast carcinoma cells, based on the MTS assay. We found that iron (II) sulphate possessed an inhibitory effect when added at 16- to 125-microM concentrations, but iron (II) sulphate became growth stimulatory when its concentration was further increased to 1000 microM. In addition, a dose-dependent increase in absorbance at the same wavelength was observed when we repeated the experiments without the addition of MTS and phenazine methosulfate. When we further repeated the cell growth determinations using adenosine triphosphate content assay for K562 and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for T47D, iron (II) sulphate showed a consistent dose-dependent growth inhibitory effect. Morphological investigation after methylene blue staining clearly demonstrated that iron (II) sulphate, at a concentration of 1000 microM, is cytotoxic to T47D cells. Interestingly, a consistent increment for the absorbance at 490 nm was further observed with increased iron (II) sulphate concentration either in the presence or absence of MTS even in a cell-free environment. Thus we conclude that iron (II) sulphate is actually growth inhibitory and even cytotoxic at high concentrations towards the K562 and T47D cancer cells and the paradoxical proliferative activity of iron (II) sulphate on these two cancer cell lines using the MTS assay was solely due to the oxidation of initial pale green iron (II) to brownish iron (III) during incubation in the aqueous condition.

The role of iron in the growth of human leukemic cell lines

The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Iron Metabolism Before Allo-Hsct in Patients with Acute Leukemia and Impact of Iron Overload on Transplantation

Iron for proliferation of cell lines and hematopoietic progenitors: Nailing down the intracellular functional iron concentration

Monoclonal Antibodies to Transferrin Receptors

Significance of the Research on the Relevance of Bone Marrowiron Stain and Serum Ferritin in the Diagnosis of Anemic Disease

Paradoxical Proliferative Potential of Iron (II) Sulphate on Cancer Cells after the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2h-tetrazolium (MTS) Assay.

Case studies: iron

[Erythropoietin Increases Transferrin Receptor Expression and the Impact of Erythropoietin on K562 Leukemic Cell Cycle].

A novel function for selenium in biological system: Selenite as a highly effective iron carrier for Chinese hamster ovary cell growth and monoclonal antibody production

Iron Dysregulation in Human Cancer: Altered Metabolism, Biomarkers for Diagnosis, Prognosis, Monitoring and Rationale for Therapy

Serum concentration effects on the kinetics and metabolism of hela-s3 cell growth and cell adaptability for successful proliferation in serum free medium

The Influence of Different Blood Serum Concentration and Medium to the Growth Curve and the Morphological Chara-cter of Invitro Culture L929 Cell Line of Mouse Fibroblasts

Iron Regulates Cellular Proliferation by Enhancing the Expression of Glucose Transporter GLUT3 in the Liver

Effects of iron deprivation on multidrug resistance of leukemic K562 cells.

Human serum alters cell culture behavior and improves spheroid formation in comparison to fetal bovine serum

[The Effect of Erythropoitin and Thyroid Hormone on K562 Iron Metabolism].

Iron-dependent Histone 3 Lysine 9 Demethylation Controls B Cell Proliferation and Humoral Immune Responses

Iron and Leukemia: New Insights for Future Treatments

Identification of Transferrin As a Progression Factor for ML-1 Human Myeloblastic Leukemia Cell Differentiation.

Iron (III) citrate inhibits polyethylenimine-mediated transient transfection of Chinese hamster ovary cells in serum-free medium